In the Journals

Legacy prescribing appears common in primary care

November 21, 2018
Legacy prescribing — prescribing drugs past their usual effective or recommended period — seemed prevalent in primary care, according to…
Meeting News

Small increase in physical activity prevents cancer, diabetes, CVD in OA patients

November 20, 2018
CHICAGO — A recent mathematical modeling analysis revealed that a modest increase in physical activity among patients with knee osteoarthritis…
FDA News

FDA issues alert regarding Pharm D Solutions products

November 20, 2018
The FDA announced today, that due to a lack of sterility assurance, it is alerting health care professionals and patients not to use drug products…
FDA News

FDA approves Gamifant, the first drug to treat hemophagocytic lymphohistiocytosis

November 20, 2018
The FDA has approved emapalumab for the treatment of both pediatric and adult patients with primary hemophagocytic lymphohistiocytosis who have…
In the Journals

Strategies needed to increase follow-up colonoscopies after advanced adenoma removal

November 20, 2018
Surveillance colonoscopies completed within the U.S. Multi-Society Task Force recommended 3-year interval following the removal of high-risk adenomas…
In the Journals Plus

Azacitidine-nivolumab combination safe, effective in certain patients with acute myeloid leukemia

November 20, 2018
The combination of azacitidine and nivolumab appeared associated with encouraging response rates and survival outcomes among patients with relapsed…
In the Journals

Boston Scientific reaches agreement to acquire BTG

November 20, 2018
Boston Scientific announced it has reached an agreement regarding a recommended offer to acquire BTG plc, which develops and makes products to treat…
Feature

Lactoferrin supplementation may alleviate chemotherapy-induced taste, smell abnormalities

November 20, 2018
Daily lactoferrin supplementation may alleviate taste and smell abnormalities experienced by individuals with cancer who undergo chemotherapy…
In the Journals Plus

Study supports weekly low-dose cisplatin for advanced head and neck squamous cell carcinoma

November 20, 2018
Patients with locally advanced head and neck squamous cell carcinoma who received weekly low-dose cisplatin with concurrent radiotherapy achieved the…
In the Journals Plus

Denosumab effective in transfusion-dependent thalassemia-induced osteoporosis

November 19, 2018
A twice-yearly injection of denosumab improved spinal bone mineral density among individuals with osteoporosis caused by transfusion-dependent…
In the Journals Plus

14 million additional adolescents needed to reach HPV vaccination goal

November 19, 2018
HPV vaccination rates among adolescents must increase substantially for the American Cancer Society to achieve its goal of 80% prevalence by 2026…
Feature

Trial to assess ibrutinib-cirmtuzumab combination for B-cell malignancies

November 19, 2018
Researchers at University of California, San Diego, are investigating whether a the addition of the monoclonal antibody cirmtuzumab to standard…

Treatment of ‘terribly disabling’ porphyria complicated by disease rarity, misdiagnosis

HemOnc Today, November 25, 2018
Clinicians are hoping an RNA interference therapeutic targeting aminolevulinic acid synthase 1, known as givosiran, will be the answer for many…
Cover Story

Advances in myeloma treatments, diagnostics have specialists ‘talking about cure’

HemOnc Today, November 25, 2018
A decade ago, patients with newly diagnosed multiple myeloma typically survived 3 to 5 years. However, the development of highly effective therapies…
Feature

Magnetic resonance spectroscopy-based method may help predict prostate cancer aggressiveness

November 18, 2018
Metabolic analysis of benign tissue samples from men with prostate cancer allowed researchers to retrospectively predict the aggressiveness of…
FDA News

FDA approves Promacta for first-line treatment of severe aplastic anemia

November 17, 2018
The FDA expanded the approval of eltrombopag to include the first-line treatment of patients with severe aplastic anemia. The indication applies to…
FDA News

FDA seeks to remove dogs from some clinical trials

November 16, 2018
The FDA outlined details of a study today that it said might allow animal drug developers to conduct certain types of research without the use of…
FDA News

FDA approves Adcetris for first-line treatment of peripheral T-cell lymphoma

November 16, 2018
The FDA expanded the approval of brentuximab vedotin to include its use with chemotherapy as first-line treatment for adults with certain types of…
Meeting News

Drug combination shows promise in rare GI cancers

November 16, 2018
A combination of dabrafenib and trametinib demonstrated promising efficacy in patients with rare gastrointestinal cancers linked to a mutation of the…
Perspective

CMS proposes revisions to improve Medicaid, CHIP managed care

November 16, 2018
CMS recently proposed a new rule to relieve regulatory burdens, strengthen accountability, enhance program integrity and promote transparency…